EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

A Distinct Immune Signature Characterizes Cirrhosis in Ethiopian Individuals With Chronic HBV Infection

Julia MacLeod iD, Fikadu G Gudissa, Asiya Jeylan, Nega Berhe, Hailemichael Desalegn, Lasse Rossvoll, Asgeir Johannessen iD, Niklas K Björkström, Dag Henrik Reikvam, Annika Niehrs

Alimentary Pharmacology & Therapeutics · 2026-10 · 64 (7) · 951-964

DOI: 10.1111/apt.70816 ↗

At a glance

Journal article in Alimentary Pharmacology & Therapeutics, published online on 2026-07-01. Written by Julia MacLeod and 9 co-authors. Institution: Institute of Clinical Medicine, University of Oslo, Oslo, Norway. Major MEDLINE topics: Hepatitis B, Chronic, Liver Cirrhosis. Cited 1 times so far (Crossref); 58 references. The full text is freely available (open access, CC BY 4.0). Funded by: Norges Forskningsråd, Nordic Society of Clinical Microbiology and Infectious Diseases, Helse Sør-Øst RHF.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background and Aims The immune cell phenotype of African patients living with chronic hepatitis B virus (HBV) infection is rarely described, despite high infection rates. This study investigated the differences in immune cell phenotypes in four distinct clinical phases of disease in an Ethiopian cohort.

Methods

Two hundred eighty‐seven patients with untreated HBV infection, and no human immunodeficiency virus and hepatitis C virus infection, were included at Adama Hospital, Ethiopia. Patients were categorized based on clinical parameters into the following groups: low‐replicative infection, “greyzone”, active hepatitis, and cirrhosis. Whole blood samples were cryopreserved using Cytodelics Whole Blood Cell Stabilizer and analysed using two high‐dimensional flow cytometry panels to define immune cell phenotypes.

Results

Patients with cirrhosis displayed a distinct immunophenotype compared to other phases of chronic HBV infection with an increase in monocytes and a reduction in all lymphocytes alongside a shift from a mature to a naïve phenotype in NK cells, CD4 + T cells, and B cells. The emergence of activated CD38 + HLA‐DR + cells across lymphocyte lineages defined patients with cirrhosis and the frequency of these double positive cells correlated positively with the AST to Platelet Ratio Index used as a measure of cirrhosis severity.

Conclusions

HBV‐associated cirrhosis in Ethiopia displayed a unique immunophenotype, in which the frequency of CD38 + HLA‐DR + NK cells and T cells correlated strongly with the severity of cirrhosis.

Subjects

MeSH terms (MEDLINE)

Hepatitis B, ChronicLiver CirrhosisHumansMaleFemaleEthiopiaAdultMiddle AgedFlow CytometryImmunophenotypingKiller Cells, NaturalPhenotypeYoung Adult

Author keywords

Africacirrhosishepatitis Bimmunophenotyping

Authors and institutions

  • Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway.
  • Adama Comprehensive Specialized Hospital Medical College, Adama, Ethiopia.
  • Department of Infectious Diseases, Vestfold Hospital, Tønsberg, Norway.
  • Aklilu Lemma Institute of Pathobiology, Addis Ababa University, Addis Ababa, Ethiopia.
  • St. Paul's Hospital Millenium Medical College, Addis Ababa, Ethiopia.

ORCID profiles: Julia MacLeod, Asgeir Johannessen

Funding

  • Norges Forskningsråd
  • Nordic Society of Clinical Microbiology and Infectious Diseases
  • Helse Sør-Øst RHF
  • John C Martin Foundation
  • Svenska Forskningsrådet Formas
  • Cancerfonden
  • Stiftelsen för Strategisk Forskning
  • Knut och Alice Wallenbergs Stiftelse

Cite

APA

MacLeod, J., Gudissa, F. G., Jeylan, A., Berhe, N., Desalegn, H., Rossvoll, L., Johannessen, A., Björkström, N. K., Reikvam, D. H., & Niehrs, A. (2026). A Distinct Immune Signature Characterizes Cirrhosis in Ethiopian Individuals With Chronic HBV Infection. Alimentary Pharmacology & Therapeutics, 64(7), 951-964. https://doi.org/10.1111/apt.70816

Vancouver

MacLeod J, Gudissa FG, Jeylan A, Berhe N, Desalegn H, Rossvoll L, et al. A Distinct Immune Signature Characterizes Cirrhosis in Ethiopian Individuals With Chronic HBV Infection. Alimentary Pharmacology & Therapeutics. 2026;64(7):951-964. doi:10.1111/apt.70816

BibTeX
@article{MacLeod2026,
  author = {MacLeod, Julia and Gudissa, Fikadu G and Jeylan, Asiya and Berhe, Nega and Desalegn, Hailemichael and Rossvoll, Lasse and Johannessen, Asgeir and Björkström, Niklas K and Reikvam, Dag Henrik and Niehrs, Annika},
  title = {A Distinct Immune Signature Characterizes Cirrhosis in Ethiopian Individuals With Chronic HBV Infection},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  volume = {64},
  number = {7},
  pages = {951--964},
  doi = {10.1111/apt.70816}
}
Start for free →